跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Novovast - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Novovast
Approved
STANDARD
Novovast
Square Pharmaceuticals Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
dbaf792c34b43a24
Company
Square Pharmaceuticals Inc.
Type
Standard
Approval Details
Approval Id
dbaf792c34b43a24
Drug Approval Philippines Name
Novovast
Product Name
Novovast
Registration Number
DRP-4972
Brand Name
Novovast
Generic Name
Simvastatin
Dosage Form
Tablet
Dosage Strength
40 mg
Manufacturer
Square Pharmaceuticals Inc.
Issuance Date
26 October 2021
Expiry Date
29 November 2026
Pharmacologic Category
HMG CoA Reductase Inhibitor
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
dbaf792c34b43a24
Type
Standard
Back to Philippines FDA Approvals